Eloxx Pharmaceuticals Inc
F:3970
Shareholder Yield
Current shareholder yield for 
Eloxx Pharmaceuticals Inc is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Eloxx Pharmaceuticals Inc
| Average Annual Return | -79.17% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -100% |
| Market Capitalization | 8.8m EUR |
| Shares Outstanding | 2 752 770 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Eloxx Pharmaceuticals Inc's latest stock split occurred on Dec 2, 2022
The company executed a 1-for-40 stock split, meaning that for every 40 shares held, investors received 1 new share.
Before the split, Eloxx Pharmaceuticals Inc traded at 3.62 per share. Afterward, the share price was about 3.62.
The adjusted shares began trading on Dec 2, 2022. This was Eloxx Pharmaceuticals Inc's 2nd stock split, following the previous one in Oct 21, 2013.
